Literature DB >> 1321233

Contributions of conserved serine residues to the interactions of ligands with dopamine D2 receptors.

B A Cox1, R A Henningsen, A Spanoyannis, R L Neve, K A Neve.   

Abstract

Four dopamine D2 receptor mutants were constructed, in each of which an alanine residue was substituted for one of four conserved serine residues, i.e., Ser-193, Ser-194, Ser-197, and Ser-391. Wild-type and mutant receptors were expressed transiently in COS-7 cells and stably in C6 glioma cells for analysis of ligand-receptor interactions. In radioligand binding assays, the affinity of D2 receptors for dopamine was decreased 50-fold by substitution of alanine for Ser-193, implicating this residue in the binding of dopamine. Each mutant had smaller decreases in affinity for one or more of the ligands tested, with no apparent relationship between the class of ligand and the pattern of mutation-induced changes in affinity, except that the potency of agonists was decreased by substitution for Ser-193. The potency of dopamine for inhibition of adenylyl cyclase was reduced substantially by substitution of alanine for Ser-193 or Ser-197. Mutation of Ser-194 led to a complete loss of efficacy for dopamine and p-tyramine, which would be consistent with an interaction between Ser-194 and the p-hydroxyl substituent of dopamine that is necessary for activation of the receptors to occur. Because mutation of the corresponding residues of beta 2-adrenergic receptors has very different consequences, we conclude that although the position of these serine residues is highly conserved among catecholamine receptors, and the residues as a group are important in ligand binding and activation of receptors by agonists, the function of each of the residues considered separately varies among catecholamine receptors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1321233     DOI: 10.1111/j.1471-4159.1992.tb09416.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  22 in total

Review 1.  Imaging transgene expression with radionuclide imaging technologies.

Authors:  S S Gambhir; H R Herschman; S R Cherry; J R Barrio; N Satyamurthy; T Toyokuni; M E Phelps; S M Larson; J Balatoni; R Finn; M Sadelain; J Tjuvajev; R Blasberg
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

2.  Receptor conformations involved in dopamine D(2L) receptor functional selectivity induced by selected transmembrane-5 serine mutations.

Authors:  J Corey Fowler; Supriyo Bhattacharya; Jonathan D Urban; Nagarajan Vaidehi; Richard B Mailman
Journal:  Mol Pharmacol       Date:  2012-03-13       Impact factor: 4.436

Review 3.  The dopamine D4 receptor: biochemical and signalling properties.

Authors:  Pieter Rondou; Guy Haegeman; Kathleen Van Craenenbroeck
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

4.  Structurally constrained hybrid derivatives containing octahydrobenzo[g or f]quinoline moieties for dopamine D2 and D3 receptors: binding characterization at D2/D3 receptors and elucidation of a pharmacophore model.

Authors:  Dennis A Brown; Prashant S Kharkar; Ingrid Parrington; Maarten E A Reith; Aloke K Dutta
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

5.  Novel bivalent ligands for D2/D3 dopamine receptors: Significant co-operative gain in D2 affinity and potency.

Authors:  Sanjib Gogoi; Swati Biswas; Gyan Modi; Tamara Antonio; Maarten E A Reith; Aloke K Dutta
Journal:  ACS Med Chem Lett       Date:  2012-10-26       Impact factor: 4.345

6.  Transmembrane segment five serines of the D4 dopamine receptor uniquely influence the interactions of dopamine, norepinephrine, and Ro10-4548.

Authors:  David F Cummings; Spencer S Ericksen; Angela Goetz; John A Schetz
Journal:  J Pharmacol Exp Ther       Date:  2010-03-09       Impact factor: 4.030

7.  The structural determinants of the bitopic binding mode of a negative allosteric modulator of the dopamine D2 receptor.

Authors:  Christopher J Draper-Joyce; Mayako Michino; Ravi Kumar Verma; Carmen Klein Herenbrink; Jeremy Shonberg; Anitha Kopinathan; Peter J Scammells; Ben Capuano; David M Thal; Jonathan A Javitch; Arthur Christopoulos; Lei Shi; J Robert Lane
Journal:  Biochem Pharmacol       Date:  2018-01-09       Impact factor: 5.858

8.  Binding of serotonin and N1-benzenesulfonyltryptamine-related analogs at human 5-HT6 serotonin receptors: receptor modeling studies.

Authors:  Małgorzata Dukat; Philip D Mosier; Renata Kolanos; Bryan L Roth; Richard A Glennon
Journal:  J Med Chem       Date:  2008-01-18       Impact factor: 7.446

9.  Critical analysis of the successes and failures of homology models of G protein-coupled receptors.

Authors:  Supriyo Bhattacharya; Alfonso Ramon Lam; Hubert Li; Gouthaman Balaraman; Michiel Jacobus Maria Niesen; Nagarajan Vaidehi
Journal:  Proteins       Date:  2013-02-14

10.  A cysteine residue in the third membrane-spanning segment of the human D2 dopamine receptor is exposed in the binding-site crevice.

Authors:  J A Javitch; X Li; J Kaback; A Karlin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.